As of 2026-03-08, the Intrinsic Value of MedCap AB (publ) (MCAP.ST) is 319.33 SEK. This MCAP.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 490.50 SEK, the upside of MedCap AB (publ) is -34.90%.
The range of the Intrinsic Value is 218.35 - 607.77 SEK
Based on its market price of 490.50 SEK and our intrinsic valuation, MedCap AB (publ) (MCAP.ST) is overvalued by 34.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 218.35 - 607.77 | 319.33 | -34.9% |
| DCF (Growth 10y) | 284.54 - 753.93 | 407.17 | -17.0% |
| DCF (EBITDA 5y) | 212.41 - 350.34 | 279.73 | -43.0% |
| DCF (EBITDA 10y) | 267.06 - 441.11 | 348.06 | -29.0% |
| Fair Value | 364.39 - 364.39 | 364.39 | -25.71% |
| P/E | 347.19 - 522.97 | 407.48 | -16.9% |
| EV/EBITDA | 185.19 - 362.30 | 256.59 | -47.7% |
| EPV | 323.10 - 438.81 | 380.95 | -22.3% |
| DDM - Stable | 142.88 - 503.56 | 323.22 | -34.1% |
| DDM - Multi | 191.04 - 535.16 | 283.00 | -42.3% |
| Market Cap (mil) | 7,396.74 |
| Beta | 1.01 |
| Outstanding shares (mil) | 15.08 |
| Enterprise Value (mil) | 7,509.24 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.37% |
| Cost of Debt | 4.25% |
| WACC | 8.06% |